SUTRO BIOPHARMA INC's ticker is STRO and the CUSIP is 869367102. A total of 110 filers reported holding SUTRO BIOPHARMA INC in Q3 2023. The put-call ratio across all filers is 1.10 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $59,937 | -24.5% | 17,273 | +1.2% | 0.00% | – |
| Q2 2023 | $79,389 | +39.8% | 17,073 | +38.9% | 0.00% | – |
| Q1 2023 | $56,794 | -42.8% | 12,293 | 0.0% | 0.00% | – |
| Q4 2022 | $99,327 | +50.5% | 12,293 | +3.0% | 0.00% | – |
| Q3 2022 | $66,000 | +6.5% | 11,933 | 0.0% | 0.00% | – |
| Q2 2022 | $62,000 | -36.7% | 11,933 | +0.1% | 0.00% | – |
| Q1 2022 | $98,000 | -44.6% | 11,923 | 0.0% | 0.00% | – |
| Q4 2021 | $177,000 | -16.1% | 11,923 | +6.9% | 0.00% | – |
| Q3 2021 | $211,000 | +1.9% | 11,156 | 0.0% | 0.00% | – |
| Q2 2021 | $207,000 | +3.5% | 11,156 | +26.9% | 0.00% | – |
| Q1 2021 | $200,000 | – | 8,790 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samsara BioCapital, LLC | 1,675,579 | $5,814,259 | 1.78% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 5,883,693 | $20,416,415 | 1.10% |
| Kynam Capital Management, LP | 1,552,675 | $5,387,782 | 0.88% |
| Parkman Healthcare Partners LLC | 1,182,168 | $4,102,123 | 0.75% |
| Rubric Capital Management LP | 3,344,810 | $11,606,491 | 0.44% |
| BVF INC/IL | 3,347,946 | $11,617,373 | 0.31% |
| DAFNA Capital Management LLC | 283,079 | $982,284 | 0.31% |
| SECTORAL ASSET MANAGEMENT INC | 432,339 | $1,500,216 | 0.29% |
| Eversept Partners, LP | 769,638 | $2,670,644 | 0.23% |
| Frazier Life Sciences Management, L.P. | 780,000 | $2,706,600 | 0.18% |